ETR:SHL

Siemens Healthineers Stock Forecast, Price & News

€46.80
+0.10 (+0.21 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
€46.06
Now: €46.80
€46.94
50-Day Range
€44.54
MA: €46.35
€47.73
52-Week Range
€35.58
Now: €46.80
€49.99
Volume467,379 shs
Average VolumeN/A
Market Capitalization$52.75 billion
P/E Ratio31.16
Dividend Yield1.70%
BetaN/A
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. The Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions and informatics products. The Advanced Therapies segment offers integrated products, solutions, and services for therapy departments of healthcare providers; and robotic-assisted platform for endo-vascular coronary and peripheral vascular interventions. This segment's principal products include angiography systems and mobile C-arms. It also provides customer value chain services, including design, maintenance, operational management, training, and education services. In addition, the company offers equipment performance management, clinical education and e-learning, asset management, and managed departmental services, as well as digital health products and services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Siemens Healthineers logo

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone49 69 6682 6602
Employees54,500
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$14.74 billion
Cash Flow€0.63 per share
Book Value€11.29 per share

Profitability

Miscellaneous

Outstanding Shares1,127,100,032
Market Cap$52.75 billion
Next Earnings Date5/3/2021 (Estimated)
OptionableNot Optionable

Headlines

Siemens Healthineers Q1 net profit jumps 44%
February 1, 2021 |  reuters.com
DAX Edges Lower On Virus Worries
January 27, 2021 |  nasdaq.com
See More Headlines

MarketRank

Overall MarketRank

1.31 out of 5 stars

Analyst Opinion: 2.2Community Rank: 2.1Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
€46.80
+0.10 (+0.21 %)
(As of 04/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SHL News and Ratings via Email

Sign-up to receive the latest news and ratings for SHL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Siemens Healthineers (ETR:SHL) Frequently Asked Questions

Is Siemens Healthineers a buy right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Siemens Healthineers in the last year. There are currently 1 sell rating, 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Siemens Healthineers stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SHL, but not buy additional shares or sell existing shares.
View analyst ratings for Siemens Healthineers
or view top-rated stocks.

What stocks does MarketBeat like better than Siemens Healthineers?

Wall Street analysts have given Siemens Healthineers a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Siemens Healthineers wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Siemens Healthineers' next earnings date?

Siemens Healthineers is scheduled to release its next quarterly earnings announcement on Monday, May 3rd 2021.
View our earnings forecast for Siemens Healthineers
.

How has Siemens Healthineers' stock been impacted by COVID-19?

Siemens Healthineers' stock was trading at €33.61 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SHL stock has increased by 39.2% and is now trading at €46.80.
View which stocks have been most impacted by COVID-19
.

Is Siemens Healthineers a good dividend stock?

Siemens Healthineers pays an annual dividend of €0.80 per share and currently has a dividend yield of 1.70%. The dividend payout ratio of Siemens Healthineers is 53.26%. This payout ratio is at a healthy, sustainable level, below 75%.
View Siemens Healthineers' dividend history.

What price target have analysts set for SHL?

14 brokers have issued 1-year price objectives for Siemens Healthineers' shares. Their forecasts range from €32.00 to €55.00. On average, they anticipate Siemens Healthineers' share price to reach €46.46 in the next twelve months. This suggests that the stock has a possible downside of 0.7%.
View analysts' price targets for Siemens Healthineers
or view top-rated stocks among Wall Street analysts.

Who are Siemens Healthineers' key executives?

Siemens Healthineers' management team includes the following people:
  • Dr. Bernhard Montag, Pres, CEO & Chairman of Management Board (Age 52, Pay $2.39M)
  • Dr. Jochen Schmitz, CFO & Member of Management Board (Age 55, Pay $1.66M)
  • Dr. Christoph Zindel, Member of Management Board (Age 60, Pay $1.28M)
  • Ms. Darleen Caron, Chief HR Officer & Member of Management Board (Age 55)
  • Mr. Marc Koebernick, Head of Investor Relations
  • Mr. Michel Therin, Pres of Advanced Therapies (Age 60)
  • Martin Fischer, Head of Fin. Diagnostics
  • Christian Klaussner, Exec. VP of Fin.
  • Mr. Deepak S. Nath, Pres of Laboratory Diagnostics (Age 48)

Who are some of Siemens Healthineers' key competitors?

What other stocks do shareholders of Siemens Healthineers own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Siemens Healthineers investors own include QUALCOMM (QCOM), Illumina (ILMN), Regeneron Pharmaceuticals (REGN), Broadcom (AVGO), Gilead Sciences (GILD), Moderna (MRNA), Koninklijke Philips (PHIA), Vertex Pharmaceuticals (VRTX), Adobe (ADBE) and Applied Materials (AMAT).

What is Siemens Healthineers' stock symbol?

Siemens Healthineers trades on the ETR under the ticker symbol "SHL."

What is Siemens Healthineers' stock price today?

One share of SHL stock can currently be purchased for approximately €46.80.

How much money does Siemens Healthineers make?

Siemens Healthineers has a market capitalization of $52.75 billion and generates $14.74 billion in revenue each year.

How many employees does Siemens Healthineers have?

Siemens Healthineers employs 54,500 workers across the globe.

What is Siemens Healthineers' official website?

The official website for Siemens Healthineers is www.healthcare.siemens.de.

How can I contact Siemens Healthineers?

The company can be reached via phone at 49 69 6682 6602.


This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.